MentalHealthDaily

1 mg Guanfacine for Self-Harm Thoughts in ADHD-PTSD-BPD Case

by GLOOM

MHD featured image for 1 mg guanfacine and self-harm thoughts in complex ADHD, PTSD, BPD, and ASD comorbidity.

A 2026 case report linked 1 mg nightly guanfacine modified-release to first-ever cessation of intrusive deliberate self-harm thoughts in a 16-year-old with attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD) traits, borderline personality disorder (BPD) traits, and post-traumatic stress disorder (PTSD). The same case became more interesting after the patient stopped taking guanfacine and the self-harm …

Methylone for Depression & PTSD: Rapid Neuroplastic Effects & More Targeted than MDMA (2024 Study)

by GLOOM

In the search for rapid, effective treatments for Post-Traumatic Stress Disorder (PTSD), the exploration of psychoactive compounds like methylone presents a new frontier. Unlike traditional treatments, methylone has shown promising rapid-acting, robust, and long-lasting antidepressant-like and anxiolytic effects in preclinical studies. By comparing its effects with MDMA, a well-known compound with similar therapeutic potential, researchers …